We are excited to announce the revival of the d-wise brand to represent Instem’s Clinical Trial Analytics and Transparency offerings. This movement returns our clinical portfolio to its roots while reinforcing our dedication to supporting and enriching the clinical research community.
Because of continued strong growth and investment in our clinical business, we’re reestablishing the d-wise brand as a more focused and robust clinical offering. This change reflects our intuitive understanding of our customers and the clinical research community as a whole, which comes from being the industry leader in SCEs. With our Accel, Aspire, and Managed Services offerings, d-wise will once again be the frontrunner in clinical trial analytics. By being customer-obsessed, we understand the challenges the community faces and have made it our priority to improve our customers’ efficiency, insight, and confidence throughout the clinical trial lifecycle.
Positioned under the Instem brand, d-wise leverages our long-standing clinical leadership, Instem’s trusted global support and expertise, and a clear, customer-obsessed approach to clinical trial analytics and transparency.
“d-wise has long been recognized as a leader in the clinical research community, and bringing back the brand reflects where we came from, where we’re going, and why we’re doing it. Our customers are looking for solutions built specifically for them, and d-wise allows us to meet their needs with clarity, strength, and focus.” Vik Krishnan, Instem CEO
Over the coming weeks and months, you’ll see a variety of ways we’re implementing these changes, from communications to our network to your experience on our website and our presence at industry events, and more. We’re committed to supporting the industry where it matters and delivering value and expertise every step of the way.
